![](/img/cover-not-exists.png)
P2.03b-053 Role of KRAS Mutation Status in NSCLC Patients Treated on SWOG S0819, a Phase III Trial of Chemotherapy with or without Cetuximab
Mack, Philipp, Moon, James, Herbst, Roy, Kim, Edward, Semrad, Thomas, Redman, Mary, Tsai, Rebekah, Solis, Leslie, Gregg, Jeffrey, Hatcher, Sandra, Varella-Garcia, Marileila, Hirsch, Fred R., Blanke, CVolume:
12
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2016.11.1334
Date:
January, 2017
File:
PDF, 328 KB
english, 2017